Eltrombopag Powder, For Suspension
Product Images NDC 31722-301

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 31722-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eltrombopagfororalsuspension125mgcarton (Eltrombopagfororalsuspension125mgcarton)

Packaging label for Eltrombopag oral suspension powder, 12.5 mg strength, by Camber Pharmaceuticals, Inc. The label includes the NDC 31722-300-31 and states the product is for oral suspension with 30 packets per container. It provides storage instructions, pharmacist dispensing guidelines, and a U.S. contact number. The label also includes warnings about not using if the packet seal is broken and directions for mixing.*

FDA Label Image

Eltrombopagfororalsuspension125mgfoil (Eltrombopagfororalsuspension125mgfoil)

Packaging label for Eltrombopag for Oral Suspension 12.5 mg by Camber Pharmaceuticals, Inc. The label includes dosage instructions referencing accompanying prescribing information and patient leaflets for mixing and use. The label also indicates the product is Rx only and bears the NDC 31722-300-12.*

FDA Label Image

Eltrombopagfororalsuspension125mgoutcarton (Eltrombopagfororalsuspension125mgoutcarton)

Packaging label for Eltrombopag for Oral Suspension 12.5 mg by Camber Pharmaceuticals, Inc. The carton contains 30 packets of powder for oral suspension, a mixing bottle, bottle lid, and oral dosing syringes. Storage instructions and pharmacist dispensing information are included, along with manufacturer data and U.S. contact information.*

FDA Label Image

Eltrombopagfororalsuspension25mgcarton (Eltrombopagfororalsuspension25mgcarton)

Packaging label for Eltrombopag oral suspension 25 mg powder, for suspension, by Camber Pharmaceuticals, Inc. The label includes NDC 31722-301-31 and states the product is for oral suspension. It contains 30 packets, each delivering 32 mg eltrombopag olamine equivalent to 25 mg eltrombopag free acid. Instructions note dispensation of a Medication Guide and storage conditions at room temperature. Manufacturer information includes Camber Pharmaceuticals, Piscataway, NJ, and Annora Pharma Pvt. Ltd., India.*

FDA Label Image

Eltrombopagfororalsuspension25mgfoil (Eltrombopagfororalsuspension25mgfoil)

Label for Eltrombopag for Oral Suspension 25 mg powder for suspension, by Camber Pharmaceuticals, Inc. The label includes a barcode, the NDC number 31722-301-25, and instructions to see accompanying prescribing information for usual dosage and patient leaflet for mixing directions. It also cautions not to use if packet seal is broken.*

FDA Label Image

Eltrombopagfororalsuspension25mgoutcarton (Eltrombopagfororalsuspension25mgoutcarton)

Packaging label for Eltrombopag for Oral Suspension 25 mg powder for suspension, oral use. The carton shows the product name and strength prominently, labeled by Camber Pharmaceuticals, Inc. It contains 30 packets with mixing bottle and dosing syringes. Includes storage instructions and a medication guide URL, with contact information for Camber Pharmaceuticals.*

FDA Label Image

Eltrombopagfororalsuspensioncamberlogo (Eltrombopagfororalsuspensioncamberlogo)

FDA Label Image

Eltrombopagfororalsuspensiondosingsyringe (Eltrombopagfororalsuspensiondosingsyringe)

A labeled instructional diagram of a syringe illustrating its main components: plunger at the rear, barrel with volume markings in milliliters (mL) from 5 to 20 mL, and syringe tip at the front. It is a grayscale line drawing with clear labels connected by lines to each part.*

FDA Label Image

Eltrombopagfororalsuspensionfigure1 (Eltrombopagfororalsuspensionfigure1)

An instructional illustration showing a hand holding a syringe drawing 20 mL of liquid from a cup. The syringe is being pulled upward from the cup, indicating measurement or withdrawal of the liquid volume.*

FDA Label Image

Eltrombopagfororalsuspensionfigure2 (Eltrombopagfororalsuspensionfigure2)

An instructional illustration showing a hand holding a container labeled for liquid medication while another hand inserts a syringe into the container to draw the suspension. The figure is labeled as 'Figure: 2,' suggesting it is part of a series of preparation or administration steps.*

FDA Label Image

Eltrombopagfororalsuspensionfigure3 (Eltrombopagfororalsuspensionfigure3)

An instructional illustration shows a pair of hands preparing oral suspension by adding powder from a sachet into a small bottle or container. The figure is labeled as Figure 3, depicting the step of combining medication powder for suspension.*

FDA Label Image

Eltrombopagfororalsuspensionfigure4 (Eltrombopagfororalsuspensionfigure4)

An instructional illustration showing a hand holding a small bottle with a screw cap, demonstrating how to twist the cap to open or close it. The image includes a circular arrow indicating the direction for twisting the cap.*

FDA Label Image

Eltrombopagfororalsuspensionfigure5 (Eltrombopagfororalsuspensionfigure5)

An instructional illustration labeled Figure 5 showing hands using a syringe to withdraw liquid from a bottle, likely demonstrating preparation or dosing of oral suspension. The syringe and bottle are depicted with measurement markings visible on the syringe barrel.*

FDA Label Image

Eltrombopagfororalsuspensionfigure6 (Eltrombopagfororalsuspensionfigure6)

An instructional illustration labeled 'Figure: 6' shows hands using a syringe to draw liquid from a small bottle with a flip-top cap. The image likely demonstrates how to prepare the oral suspension of Eltrombopag, a powder for suspension drug from Camber Pharmaceuticals.*

FDA Label Image

Eltrombopagfororalsuspensionfigure7 (Eltrombopagfororalsuspensionfigure7)

Illustration showing a child receiving oral medication via a syringe. A hand is administering liquid medicine into the child's mouth from the syringe, demonstrating proper oral dosing technique for liquid formulations such as powder for suspension.*

FDA Label Image

Eltrombopagfororalsuspensionmixingbottle (Eltrombopagfororalsuspensionmixingbottle)

An instructional diagram showing a container with a lid and a separate cap attached by a flexible strap. The diagram labels the two parts as 'Cap' and 'Lid,' illustrating their relative positions on the container.*

FDA Label Image

Eltrombopagfororalsuspensionpacket (Eltrombopagfororalsuspensionpacket)

Eltrombopag powder for suspension is shown in a white packet-style single-dose pouch. The image does not display any visible text or markings. The product is an oral prescription drug labeled by Camber Pharmaceuticals, Inc.*

FDA Label Image

Eltrombopagfororalsuspensionstructure (Eltrombopagfororalsuspensionstructure)

Chemical structure of Eltrombopag olamine shown as a molecular diagram with rings, bonds, and functional groups representing the compound used in the prescription drug Eltrombopag powder for oral suspension by Camber Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.